Goldenwell Biotech (GWLL) Inventory (2021 - 2025)

Goldenwell Biotech has reported Inventory for 5 years, with the latest figure at $174788.0 in Q3 2025.

• For the quarter ending Q3 2025, Inventory changed 0.06% year-over-year to $174788.0; the trailing twelve-month figure through Sep 2025 stood at $174788.0 (changed 0.06% YoY), and the FY2024 full-year result was $174788.0, changed 0.04% from the prior year.
• Inventory for Q3 2025 stood at $174788.0, roughly flat from $174788.0 in the prior quarter.
• The five-year high for Inventory was $205725.0 in Q2 2021, with the low at $103125.0 in Q1 2021.
• Historically, Inventory has averaged $177842.1 across 5 years, with a median of $175013.0 in 2023.
• The largest YoY upside for Inventory was 92.47% in 2022 against a maximum downside of 12.18% in 2022.
• Goldenwell Biotech's Inventory stood at $198671.0 in 2021, then slipped by 11.38% to $176058.0 in 2022, then dropped by 0.68% to $174863.0 in 2023, then fell by 0.04% to $174788.0 in 2024, then changed by 0.0% to $174788.0 in 2025.
• The last three Inventory figures came in at $174788.0 (Q3 2025), $174788.0 (Q2 2025), and $174788.0 (Q1 2025), per Business Quant data.